This article is more than 5 years old. Information may no longer be current.

Smith & Nephew withdraws hip component from market

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Smith & Nephew has initiated a voluntary market withdrawl of the optional metal liner component of its R3 Acetabular System, according to a company press release.

Since the component was introduced in 2007 and launched globally in 2009, approximately 7,700 metal-liners have been implanted. Overall, the majority of the metal-liners have been used in stemmed total hip replacement.

“We regularly review the effectiveness of our products and are not satisfied with the clinical results of this component,” Andy Weymann, MD, chief medical officer of Smith & Nephew, said in the release. “As with all medical devices, anyone experiencing unusual symptoms should contact their surgeon.”

According to the release, the withdrawl does not affect the current practice for patient follow-up care for the component or impact other R3 System liners.